Kevin J. Yeaman Sells 18,548 Shares of Dolby Laboratories, Inc. (DLB) Stock

Dolby Laboratories, Inc. (NYSE:DLB) CEO Kevin J. Yeaman sold 18,548 shares of Dolby Laboratories stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $61.40, for a total transaction of $1,138,847.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Kevin J. Yeaman also recently made the following trade(s):

  • On Monday, February 12th, Kevin J. Yeaman sold 68,548 shares of Dolby Laboratories stock. The shares were sold at an average price of $59.66, for a total transaction of $4,089,573.68.
  • On Thursday, February 8th, Kevin J. Yeaman sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.32, for a total transaction of $3,066,000.00.
  • On Thursday, February 8th, Kevin J. Yeaman sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.33, for a total transaction of $6,233,000.00.
  • On Monday, December 18th, Kevin J. Yeaman sold 11,130 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.47, for a total transaction of $695,291.10.
  • On Tuesday, December 19th, Kevin J. Yeaman sold 17,590 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.45, for a total transaction of $1,098,495.50.

Shares of Dolby Laboratories, Inc. (NYSE:DLB) opened at $63.04 on Thursday. The company has a market cap of $6,530.00, a price-to-earnings ratio of 100.06, a PEG ratio of 5.26 and a beta of 0.78. Dolby Laboratories, Inc. has a 1 year low of $48.00 and a 1 year high of $74.29.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Wednesday, January 24th. The electronics maker reported $0.79 EPS for the quarter, topping the Zacks’ consensus estimate of $0.44 by $0.35. The business had revenue of $287.80 million for the quarter, compared to analyst estimates of $265.75 million. Dolby Laboratories had a net margin of 6.06% and a return on equity of 12.02%. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.66 earnings per share. equities analysts anticipate that Dolby Laboratories, Inc. will post 0.99 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 14th. Stockholders of record on Monday, February 5th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date was Friday, February 2nd. Dolby Laboratories’s dividend payout ratio is presently 101.59%.

A number of research analysts have weighed in on the stock. Zacks Investment Research lowered shares of Dolby Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, January 29th. B. Riley lowered shares of Dolby Laboratories to a “hold” rating and set a $63.00 price target on the stock. in a research note on Thursday, January 25th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Dolby Laboratories from $63.00 to $70.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. Dolby Laboratories currently has a consensus rating of “Hold” and an average price target of $62.00.

Several hedge funds have recently made changes to their positions in DLB. Ameriprise Financial Inc. lifted its position in shares of Dolby Laboratories by 14.3% in the second quarter. Ameriprise Financial Inc. now owns 17,882 shares of the electronics maker’s stock worth $862,000 after purchasing an additional 2,232 shares in the last quarter. Northern Trust Corp lifted its position in shares of Dolby Laboratories by 0.3% in the second quarter. Northern Trust Corp now owns 273,724 shares of the electronics maker’s stock worth $13,401,000 after purchasing an additional 836 shares in the last quarter. Virtu KCG Holdings LLC bought a new stake in shares of Dolby Laboratories in the second quarter worth $366,000. Dimensional Fund Advisors LP lifted its position in shares of Dolby Laboratories by 0.5% in the second quarter. Dimensional Fund Advisors LP now owns 536,657 shares of the electronics maker’s stock worth $26,276,000 after purchasing an additional 2,648 shares in the last quarter. Finally, Balyasny Asset Management LLC lifted its position in shares of Dolby Laboratories by 400.6% in the second quarter. Balyasny Asset Management LLC now owns 19,433 shares of the electronics maker’s stock worth $951,000 after purchasing an additional 15,551 shares in the last quarter. 52.74% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/15/kevin-j-yeaman-sells-18548-shares-of-dolby-laboratories-inc-dlb-stock.html.

About Dolby Laboratories

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply